GlassScriptPhysician profile
Darlyne Cange
NPI 1508904772
$1,063.30
in general payments reported to CMS, 2019-2025
15 companies · $85.83 in 2025
The $85.83 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $48.27 · 2022: $279 · 2023: $235 · 2024: $163 · 2025: $85.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $180.55 | 2022-2023 | Senza |
| Bioventus LLC | $145.28 | 2022 | |
| Convatec INC. | $142.90 | 2024 | |
| Melinta Therapeutics, LLC | $124.97 | 2019 | |
| Triad Life Sciences INC. | $112.04 | 2022 | |
| Globus Medical, INC. | $85.83 | 2025 | Senza |
| Musculoskeletal Transplant Foundation INC. | $78.11 | 2019 | |
| Horizon Therapeutics Plc | $52.87 | 2020-2023 | Krystexxa |
| Organogenesis INC. | $29.51 | 2020 | |
| Averitas Pharma INC. | $22.87 | 2023 | Qutenza |
| Amgen INC. | $20.42 | 2024 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.69 | 2023 | Arazlo |
| Theratechnologies INC. | $18.41 | 2019 | |
| Sandoz INC. | $16.61 | 2019 | |
| Kerecis Limited | $14.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darlyne Cange listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.